July 21, 2011

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

September 14, 2010

The Food and Drug Administration has extended the amount of review time for an AstraZeneca...